SGLT Inhibitors

Isoform-selective Products

Cat.No. Product Name Information Product Use Citations Product Validations
S8022 BI-10773 (Empagliflozin) Empagliflozin is a potent and selective SGLT-2 inhibitor with IC50 of 3.1 nM, exhibits >300-fold selectivity over SGLT-1, 4, 5 and 6. Phase 3.
Redox Biol, 2024, 69:103010
Biomed Pharmacother, 2024, 180:117453
Sci Rep, 2024, 14(1):16459
Verified customer review of BI-10773 (Empagliflozin)
S2760 Canagliflozin (JNJ-28431754) Canagliflozin (TA 7284, JNJ 28431754) is a highly potent and selective SGLT2 inhibitor for hSGLT2 with IC50 of 2.2 nM in a cell-free assay, exhibits 413-fold selectivity over hSGLT1.
Redox Biol, 2024, 71:103103
Toxicol Appl Pharmacol, 2024, 495:117183
J Clin Invest, 2023, 133(1)e154754
Verified customer review of Canagliflozin (JNJ-28431754)
S1548 Dapagliflozin (BMS-512148) Dapagliflozin is a potent and selective hSGLT2 inhibitor with EC50 of 1.1 nM, exhibiting 1200-fold selectivity over hSGLT1. Phase 4.
Cell Death Dis, 2025, 16(1):79
Sci Adv, 2025, 11(31):eadu3700
Eur Heart J, 2024, 31:ehae472.
Verified customer review of Dapagliflozin (BMS-512148)
S8103 Sotagliflozin (LX4211) Sotagliflozin is an oral dual SGLT1/SGLT2 inhibitor with IC50 of 36 nM and 1.8 nM, respectively. Phase 3.
Cell Rep, 2024, 43(2):113675
Front Endocrinol (Lausanne), 2023, 14:1069715
Front Cardiovasc Med, 2023, 10:1064290
S2343 Phlorizin Phlorizin (Phloridzin) is a dihydrochalcone found in the bark of pear (Pyrus communis), apple, cherry and other fruit trees. This compound is a non-selective SGLT inhibitor with Ki of 300 nM and 39 nM for hSGLT1 and hSGLT2, respectively. It is also a Na+/K+-ATPase inhibitor.
Mol Ther Methods Clin Dev, 2022, 24:11-19
J Ginseng Res, 2022, 46(5):700-709
J Med Virol, 2019, 91(8):1440-1447
Verified customer review of Phlorizin
S2342 Phloretin (RJC 02792) Phloretin (RJC 02792, NSC 407292, Dihydronaringenin) is a dihydrochalcone found in apple tree leaves, and it shows beneficial effects on diabetes.
Br J Pharmacol, 2022, 10.1111/bph.15896
Food Funct, 2020, 10.1039/d0fo02362k
J Med Virol, 2019, 91(8):1440-1447
Verified customer review of Phloretin (RJC 02792)
S5901 Canagliflozin hemihydrate Canagliflozin hemihydrate is the hemihydrate form of canagliflozin, which is a SGLT2 inhibitor with IC50 of 2.2 nM for hSGLT2 in a cell-free assay, exhibits 413-fold selectivity over hSGLT1.
Front Pharmacol, 2022, 13:848310
Yonsei Med J, 2022, 63(7):619-631
Cell Death Dis, 2018, 9(2):226
S5566 Dapagliflozin propanediol monohydrate Dapagliflozin propanediol belongs to the class of orally administered antidiabetic agents designated as sodiumglucose cotransporter 2 (SGLT2) inhibitors.
J Cell Mol Med, 2025, 29(11):e70581
Am J Physiol Renal Physiol, 2019, 316(5):F1078-F1089
S8558 Tofogliflozin(CSG 452) Tofogliflozin (CSG 452) is a novel sodium-glucose co-transporter 2(SGLT2) inhibitor, with IC50 values of 2.9 nM and 8444 nM for hSGLT2 and hSGLT1, respectively.
S0994 Ipragliflozin L-Proline Ipragliflozin L-Proline is an orally active and selective inhibitor of SGLT2 with IC50 of 7.38 nM, 6.73 nM and 5.64 nM for human SGLT2, rat SGLT2 and mouse SGLT2, respectively.

Signaling Pathway Map